NPDPA is a dissociative anesthetic that has been sold online as a designer drug. It was first identified in Germany in 2008, and while it has never been as widely sold as related compounds such as diphenidine and ephenidine, it has continued to show up in seized drug samples occasionally, and was banned in Sweden in 2015.
NPDPA molecular structure diagram from the DrugsPRO substance library.
Also known as: N-(1,2-diphenylethyl)propan-2-amine
Classification
Psychoactive: Dissociative
Effects
Numbness
Loss Of Balance
Incoordination
Stimulation
Sedation
Disconnection
Euphoria
Time Dilation
Dissociation
Dizziness
Derealization
Open Eye Visuals
Closed Eye Visuals
Patterning
Dulled Perception
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
NPDPA - DrugsPRO ainejuhend
NPDPA: NPDPA is a dissociative anesthetic that has been sold online as a designer drug. It was first identified in Germany in 2008, and while it has never been as widely sold as related compounds such as diphenidine and ephenidine, it has continued to show up in seized drug samples occasionally, and